| 000 | 01870 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517033641.0 | ||
| 264 | 0 | _c20170329 | |
| 008 | 201703s 0 0 eng d | ||
| 022 | _a1520-5762 | ||
| 024 | 7 |
_a10.3109/03639045.2015.1038273 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFeutry, Frédéric | |
| 245 | 0 | 0 |
_aStability of 10 mg/mL cefuroxime solution for intracameral injection in commonly used polypropylene syringes and new ready-to-use cyclic olefin copolymer sterile vials using the LC-UV stability-indicating method. _h[electronic resource] |
| 260 |
_bDrug development and industrial pharmacy _cJan 2016 |
||
| 300 |
_a166-174 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCefuroxime _xadministration & dosage |
| 650 | 0 | 4 |
_aCycloparaffins _xchemistry |
| 650 | 0 | 4 |
_aDrug Compounding _xstandards |
| 650 | 0 | 4 |
_aDrug Packaging _xmethods |
| 650 | 0 | 4 | _aDrug Stability |
| 650 | 0 | 4 | _aDrug Storage |
| 650 | 0 | 4 |
_aEndophthalmitis _xprevention & control |
| 650 | 0 | 4 | _aFeasibility Studies |
| 650 | 0 | 4 | _aGlass |
| 650 | 0 | 4 | _aInjections, Intraocular |
| 650 | 0 | 4 | _aOsmolar Concentration |
| 650 | 0 | 4 |
_aPharmaceutical Solutions _xadministration & dosage |
| 650 | 0 | 4 |
_aPolypropylenes _xchemistry |
| 650 | 0 | 4 |
_aPostoperative Complications _xprevention & control |
| 650 | 0 | 4 | _aSyringes |
| 650 | 0 | 4 | _aTemperature |
| 700 | 1 | _aSimon, Nicolas | |
| 700 | 1 | _aGenay, Stéphanie | |
| 700 | 1 | _aLannoy, Damien | |
| 700 | 1 | _aBarthélémy, Christine | |
| 700 | 1 | _aDécaudin, Bertrand | |
| 700 | 1 | _aLabalette, Pierre | |
| 700 | 1 | _aOdou, Pascal | |
| 773 | 0 |
_tDrug development and industrial pharmacy _gvol. 42 _gno. 1 _gp. 166-174 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/03639045.2015.1038273 _zAvailable from publisher's website |
| 999 |
_c24931785 _d24931785 |
||